MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
909.95%
Quick Ratio
879.84%
Cash Ratio
475.38%
Debt to Asset Ratio
13.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Long-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Treasury stock at cost 18,580 sh...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
270,026
265,772
120,863
129,418
Short-term investments
206,693
189,404
66,712
65,485
Accounts receivable, net
15,747
16,637
13,431
13,536
Inventory
17,103
18,594
19,981
25,418
Prepaid expenses and other current assets
7,298
6,046
4,871
7,906
Contingent consideration receivable
-
25,000
-
-
Current assets held for sale
0
0
228,406
230,676
Total current assets
516,867
521,453
454,264
472,439
Property and equipment, gross
65,475
65,310
66,537
67,438
Less accumulated depreciation and amortization
50,735
49,030
48,162
47,075
Construction-in-progress
560
823
900
375
Property and equipment, net
15,300
17,103
19,275
20,738
Operating lease right-of-use asset, net
24,246
25,545
26,732
23,453
Other non-current assets
3,261
3,386
3,154
3,521
Long-term investments
67,280
71,357
25,701
19,485
Deferred tax asset, non-current
264
270
38,628
-
Non-current assets held for sale
-
-
0
0
Total assets
627,218
639,114
567,754
539,636
Accounts payable
9,554
8,007
5,407
6,619
Accrued liabilities
29,608
15,684
29,783
30,810
Operating lease liabilities, current
5,621
5,540
5,490
5,113
Deferred revenue, current
9,144
9,981
38,949
40,111
Deferred grant income, current
2,875
2,991
3,046
3,098
Current liabilities held for sale
0
0
25,633
22,214
Total current liabilities
56,802
42,203
108,308
107,965
Convertible notes, non-current
299
299
299
299
Deferred tax liability
823
823
810
1,139
Operating lease liabilities, non-current
22,167
23,652
25,038
21,977
Deferred revenue, non-current
3,146
3,013
3,503
2,366
Deferred grant income, non-current
2,896
3,557
4,290
5,031
Other non-current liabilities
1,114
4,444
1,215
1,200
Non-current liabilities held for sale
-
-
-
0
Total liabilities
87,247
77,991
143,463
139,977
Common stock 0.001 par value, 600,000 shares authorized at june 30, 2026 and december 31, 2025 410,701 and 404,961 shares issued at june 30, 2026 and december 31, 2025, respectively 392,121 and 386,381 shares outstanding at june 30, 2026 and december 31, 2025, respectively
410
408
404
401
Additional paid-in capital
1,745,082
1,741,172
1,732,393
1,726,032
Accumulated other comprehensive income (loss)
1,183
-511
-1,492
-477
Accumulated deficit
-1,160,237
-1,133,479
-1,260,547
-1,279,830
Treasury stock at cost 18,580 shares at june 30, 2026 and december 31, 2025
46,467
46,467
46,467
46,467
Total stockholders' equity
539,971
561,123
424,291
399,659
Total liabilities and stockholders' equity
627,218
639,114
567,754
539,636
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$270,026K (70.24%↑ Y/Y)Short-term investments$206,693K (163.41%↑ Y/Y)Inventory$17,103K (-29.24%↓ Y/Y)Accounts receivable, net$15,747K (7.77%↑ Y/Y)Prepaid expenses andother current assets$7,298K (3.06%↑ Y/Y)Property and equipment,gross$65,475K (-2.55%↓ Y/Y)Construction-in-progress$560K (18.39%↑ Y/Y)Total current assets$516,867K (2.14%↑ Y/Y)Long-term investments$67,280K Operating leaseright-of-use asset, net$24,246K (-1.31%↓ Y/Y)Property and equipment,net$15,300K (-32.53%↓ Y/Y)Other non-currentassets$3,261K (-11.43%↓ Y/Y)Deferred tax asset,non-current$264K Less accumulateddepreciation and...$50,735K (12.79%↑ Y/Y)Total assets$627,218K (12.61%↑ Y/Y)Total liabilities andstockholders' equity$627,218K (12.61%↑ Y/Y)Total stockholders'equity$539,971K (27.19%↑ Y/Y)Total liabilities$87,247K (-34.12%↓ Y/Y)Accumulated deficit-$1,160,237K (6.82%↑ Y/Y)Treasury stock at cost18,580 shares at june...$46,467K (0.00%↑ Y/Y)Additional paid-in capital$1,745,082K (1.60%↑ Y/Y)Total currentliabilities$56,802K (-42.05%↓ Y/Y)Operating leaseliabilities, non-current$22,167K (-4.55%↓ Y/Y)Deferred revenue,non-current$3,146K (12.92%↑ Y/Y)Deferred grant income,non-current$2,896K (-49.78%↓ Y/Y)Other non-currentliabilities$1,114K (-10.88%↓ Y/Y)Deferred tax liability$823K (-23.87%↓ Y/Y)Convertible notes,non-current$299K (0.00%↑ Y/Y)Accumulated othercomprehensive income (loss)$1,183K (161.36%↑ Y/Y)Common stock 0.001 parvalue, 600,000 shares...$410K (2.50%↑ Y/Y)Accrued liabilities$29,608K (22.31%↑ Y/Y)Accounts payable$9,554K (30.36%↑ Y/Y)Deferred revenue,current$9,144K (-77.24%↓ Y/Y)Operating leaseliabilities, current$5,621K (10.35%↑ Y/Y)Deferred grant income,current$2,875K (-11.35%↓ Y/Y)

STANDARD BIOTOOLS INC. (LAB)

STANDARD BIOTOOLS INC. (LAB)